58 related articles for article (PubMed ID: 29962816)
1. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
[TBL] [Abstract][Full Text] [Related]
2. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.
ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE
Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165
[TBL] [Abstract][Full Text] [Related]
3. Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma.
Pratama MY; Cavalletto L; Tiribelli C; Chemello L; Pascut D
Sci Rep; 2020 Feb; 10(1):3128. PubMed ID: 32081930
[TBL] [Abstract][Full Text] [Related]
4. MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma.
Yang C; Du P; Lu W
Cancer Biother Radiopharm; 2023 Dec; 38(10):670-673. PubMed ID: 34287021
[No Abstract] [Full Text] [Related]
5. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
Jiang Y; He J; Li Y; Guo Y; Tao H
Biomed Res Int; 2019; 2019():5179048. PubMed ID: 31871941
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Xue X; Zhao Y; Wang X; Qin L; Hu R
J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
[TBL] [Abstract][Full Text] [Related]
7. microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
Fattahi M; Rezaee D; Fakhari F; Najafi S; Aghaei-Zarch SM; Beyranvand P; Rashidi MA; Bagheri-Mohammadi S; Zamani-Rarani F; Bakhtiari M; Bakhtiari A; Falahi S; Kenarkoohi A; Majidpoor J; Nguyen PU
Cell Death Discov; 2023 Nov; 9(1):423. PubMed ID: 38001121
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers.
Ranković B; Hauptman N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895131
[TBL] [Abstract][Full Text] [Related]
9. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment.
Wang L; Peng JL
Sci Rep; 2023 Jul; 13(1):10755. PubMed ID: 37400463
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2.
Niture S; Gadi S; Qi Q; Gyamfi MA; Varghese RS; Rios-Colon L; Chimeh U; Vandana ; Ressom HW; Kumar D
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980601
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Cancer: Genetic Conditions and Epigenetic Alterations.
Montalvo-Javé EE; Nuño-Lámbarri N; López-Sánchez GN; Ayala-Moreno EA; Gutierrez-Reyes G; Beane J; Pawlik TM
J Gastrointest Surg; 2023 May; 27(5):1001-1010. PubMed ID: 36749558
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
Yu B; Zhou S; Liang H; Ye Q; Wang Y
Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217
[TBL] [Abstract][Full Text] [Related]
14. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma.
Debes JD; Romagnoli PA; Prieto J; Arrese M; Mattos AZ; Boonstra A; On Behalf Of The Escalon Consortium
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918270
[TBL] [Abstract][Full Text] [Related]
15. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
[TBL] [Abstract][Full Text] [Related]
16. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway.
Cao X; Zhang J; Apaer S; Yao G; Li T
Int J Gen Med; 2021; 14():89-102. PubMed ID: 33469348
[TBL] [Abstract][Full Text] [Related]
17. Functional mechanism and clinical implications of MicroRNA-423 in human cancers.
Ke R; Lv L; Zhang S; Zhang F; Jiang Y
Cancer Med; 2020 Dec; 9(23):9036-9051. PubMed ID: 33174687
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
Mocan T; Simão AL; Castro RE; Rodrigues CMP; Słomka A; Wang B; Strassburg C; Wöhler A; Willms AG; Kornek M
J Clin Med; 2020 May; 9(5):. PubMed ID: 32443747
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Zhao XF; Li N; Lin DD; Sun LB
Biomed Res Int; 2020; 2020():5353695. PubMed ID: 32309434
[TBL] [Abstract][Full Text] [Related]
20. The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells.
Liu Z; Ma C; Tang X; Tang Q; Lou L; Yu Y; Zheng F; Wu J; Yang XB; Wang W; Hann SS
Front Oncol; 2019; 9():1081. PubMed ID: 31681610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
